This study employed network pharmacology and bioinformatics analysis to identify two biomarkers (COL4A6 and NKX3-1) closely associated with the ISR pathway during JWSTZYD treatment for osteoporosis. The gene discussed is NKX3-1; the disease is osteoporosis.